Evaluation of Inflammation of the Anterior Segment by Laser Flashmeter in Patients Having Undergone Surgery of the Posterior Segment (Vitrectomy or Preindentation) During the First Postoperative Year. (FLAVIC) (FLAVIC)

September 17, 2018 updated by: Rennes University Hospital
Observational study, monocentric, prospective, descriptive and comparative (eye operated vs fellow eye).

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

After surgery by vitrectomy or preindentation, an anti-inflammatory treatment is conventionally prescribed for a duration of 1 month. However, frequently, during the post-operative control at one month, there may be signs of ocular inflammation or symptoms of discomfort justifying the prolongation of post-operative treatment. A 2012 study evaluated post-operative flare follow-up in 22 vitrectomized patients for retinal detachment, and showed a significantly higher flare 3 months after surgery, compared to the other eye and pre-surgery value.

In this study, the investigators wish to study postoperative inflammation in patients operated for posterior segment ocular surgery (vitrectomy or preindentation) measured by laser flashmeter on a follow-up of one year.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Major patient undergoing vitrectomy or preindentation in the ophthalmology department of Rennes University Hospital

Description

Inclusion Criteria:

  • Major patient,
  • Operation of vitrectomy or preindentation in the ophthalmology department of Rennes University Hospital for one of the following reasons:
  • Retinal detachment, rhegmatogenous or not
  • Combined surgery
  • Membrane peeling
  • Macular hole
  • Optically targeted vitrectomy (Terson's syndrome, intravitreous haemorrhage)
  • Covered by a health insurance system,
  • Having received information on the protocol and not having expressed opposition to participating in the study

Exclusion Criteria:

  • Vitrectomy for endophthalmitis or posterior uveitis,
  • Patient with vitreoretinal proliferation (grade B and C),
  • Pregnant or nursing woman,
  • Major patient subject to legal protection (safeguard of justice, guardianship, guardianship), person deprived of liberty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of the flare value
Time Frame: Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures
Evolution of the flare value preoperatively and then to D7, M1, M2, M3, M6, M12 of the operated eye
Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Flare values of the fellow eye and the operated eye
Time Frame: Difference between flare values of the fellow eye and the operated eye at each evaluation time : baseline (preoperatively), day 7, month 1, month 2, month 3, month 6, and month 12
Flare value of the fellow eye and the operated eye at each evaluation time
Difference between flare values of the fellow eye and the operated eye at each evaluation time : baseline (preoperatively), day 7, month 1, month 2, month 3, month 6, and month 12

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Flare value of the operated eye
Time Frame: Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures
Flare value of the operated eye preoperatively and at each evaluation time
Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
Identification of criteria associated with high inflammation : indication of surgery
Baseline (preoperatively)
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
Identification of criteria associated with high inflammation : ophthalmologic antecedents
Baseline (preoperatively)
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
Identification of criteria associated with high inflammation : high preoperative IOP
Baseline (preoperatively)
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
Identification of criteria associated with high inflammation : BCVA (better visual acuity corrected) preoperatively
Baseline (preoperatively)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dalal ASRI, Rennes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2018

Primary Completion (Anticipated)

July 1, 2020

Study Completion (Anticipated)

July 1, 2020

Study Registration Dates

First Submitted

May 17, 2018

First Submitted That Met QC Criteria

September 17, 2018

First Posted (Actual)

September 19, 2018

Study Record Updates

Last Update Posted (Actual)

September 19, 2018

Last Update Submitted That Met QC Criteria

September 17, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 35RC18_3043_FLAVIC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation Eye

Clinical Trials on Laser Flare Meter

3
Subscribe